Erlotinib carboxylic acid
CAS: 882420-21-5
Ref. 3D-HKB42021
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Erlotinib is a small molecule that is used as a research tool to study the function of ion channels and receptor-ligand interactions. It has been shown to activate phosphatidylinositol 3-kinase (PI3K) and inhibit protein tyrosine kinases, which are important for signal transduction in cells. Erlotinib binds to the epidermal growth factor receptor (EGFR), which is an important drug target in cancer therapy.
The 6-fluoro-3-indoxyl-beta-D-galactopyranoside is an antituberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on human
